Two U.S. lawmakers with jurisdiction over the Medicaid program are seeking answers from seven of the nation’s largest Medicaid Managed Care Organizations (MCOs) about the MCO's high rates of prior authorization denials for patients.
House Energy and Commerce Committee Ranking Member Frank Pallone (D-NJ) and Senate Finance Committee Chair Ron Wyden (D-OR) sent letters to the MCOs after an “alarming” report by the Department of Health and Human Services (HHS) Inspector General found that numerous MCOs had “staggeringly high rates of denial of health services for patients.”
The letters, which request more information including explanations of how certain benefits are categorized, were sent to the chief executives of: CVS Health’s Aetna, AmeriHealth Caritas, CareSource, Centene, Elevance, Molina Healthcare and United Healthcare Community & State. Responses are due by October 31.
Medicaid, which is funded jointly by states and the federal government, is one of the country's largest healthcare providers. It provides health insurance to millions of people including low-income adults, children, pregnant women, elderly adults and people with disabilities, according to the HHS website.
More than 70 million low-income Americans are enrolled in Medicaid MCOs, which are responsible for ensuring that they can access the necessary care that they are legally entitled to, Pallone and Wyden said in a statement.
“While plans may use prior authorization as a means to manage care, this (HHS) report raises serious questions about whether plans are improperly using prior authorization to deny care,” they said.
Denial rates more than double Medicare Advantage rate
The report found that MCOs denied an average of one out of every eight (12.5%) prior authorization requests for service, which is more than double the Medicare Advantage denial rate. In 2019, according to the report, Medicare Advantage health care plans denied only 5.7% of prior authorization requests.
Among the 115 MCOs that the Inspector General reviewed, 12 had prior authorization denial rates greater than 25%, which is twice the overall rate.
“Although any individual prior authorization denial may be appropriate, it is unclear why some MCOs had rates of prior authorization denials that were so much higher than their peers,” according to the HHS report.
The report’s findings “raise serious concerns that Medicaid MCOs are systematically and improperly denying necessary care, which they are required by law to provide,” Pallone and Wyden said. “Low-income children and families, seniors, and people with disabilities rely on these plans for access to critical health care services, and prior authorization denials prevent them from receiving these services, which can lead to worse health outcomes.”
States pay MCOs a specified amount per member per month, which is meant to cover the expected costs of care for each enrolled beneficiary, they said, adding that the concern is about whether this may be creating financial incentives for the MCOs to increase profits by denying requests for care.
To find out more about the Medicaid program, including features such as inpatient and outpatient hospital services, as well as physician and home health services, visit the Medicaid.gov website.
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
How to Buy Stocks
Not everyone knows how to buy stocks, even as investing in the stock market becomes more and more popular. This four-step plan can help.
By Will Ashworth Published
One Key Rule for Understanding 2023 RMDs
RMDs Required minimum distribution (RMD) rules can be confusing, but there is a guideline that can help.
By Kelley R. Taylor Published
Costs of 34 Medicare Drugs To Be Capped at $618 Until December
Medicare rebate program to cut out-of-pocket costs for certain Part B drugs from October through December.
By Joey Solitro Published
Hospitals Say Increased Medicare Reimbursement Is Not Enough: Kiplinger Economic Forecasts
Economic Forecasts Medicare will bump up hospital reimbursements by 3.1% in 2024, but the industry says it's not enough as it comes off its worst financial year of the pandemic.
By Matthew Housiaux Published
More Weight-Loss Drugs, Like Ozempic, are in the Works: Kiplinger Economic Forecasts
Economic Forecasts Pharmaceutical companies are developing more weight-loss drugs similar to Ozempic, but these injectables are still expensive.
By John Miley Published
Amazon launches RxPass — its new subscription service for medication
Amazon's new program, RxPass, lets Prime members ship prescription medications to their homes for just $5 a month.
By Erin Bendig Published
Everything You Need to Know About The Health Care Tax Credit
Need to get health insurance through an Affordable Care Act exchange? You may be eligible for help.
By Joy Taylor Last updated
Considering a Medicare Advantage Plan? Be Wary of Promises
These private insurance alternatives to Medicare are growing in popularity at the same time they’re under scrutiny for their sales tactics and coverage.
By Elaine Silvestrini Last updated
Medicare Costs to Go Down in 2023
Retirement Lower-than-expected spending on an expensive drug and other things means beneficiaries will pay less next year.
By Elaine Silvestrini Last updated
Inflation Reduction Act Boosts Obamacare Tax Credit
Tax Breaks Enhancements to the premium tax credit are extended for three more years under the Inflation Reduction Act.
By Rocky Mengle Published